COVID-19 Information

Sellers Dorsey is tracking and assessing the large volume of information coming from the Trump Administration, Congress, CMS, and state governments regarding Medicaid and COVID-19. We are focusing significant effort on delivering guidance to our healthcare clients, particularly those on all sides of Medicaid, to help position them to remain financially secure, serve their populations, and advocate for their needs during this unprecedented situation.

Our team has created a summary of the impact of COVID-19 on federal Medicaid waiver authorities and additional resources to address COVID-19.

We will update this summary as information becomes available.

States with 1135 waiver approvals
Appendix K 1915(c ) waiver approvals
Covid-19 1115 waiver requests

Updated September 10, 2020

As of September 9, CMS has approved 118 Section 1135 waiver requests for states and territories, including multiple subsequent approvals. An asterisk indicates more than one approval. No new approvals this week.
Alabama* | Alaska* | Arizona* | Arkansas* | California* | CNMI | Colorado* | Connecticut* | Delaware* | District of Columbia* | Florida | Georgia* | Hawaii | Idaho | Illinois | Indiana* | Iowa* | Kansas | Kentucky | Louisiana* | Maine* | Maryland* | Massachusetts* | Michigan | Minnesota* | Mississippi* | Missouri* | Montana* | Nebraska* | New Hampshire* | New Jersey* | New Mexico* | New York* | Nevada | North Carolina* | North Dakota* | Ohio* | Oklahoma* | Oregon* | Pennsylvania* | Puerto Rico | Rhode Island* | South Carolina* | South Dakota* | Tennessee* | Texas* | US Virgin Islands | Utah | Vermont* | Virginia* | Washington* | West Virginia* | Wisconsin* | Wyoming*

CMS has approved Appendix K submissions for state 1915(c) waivers for 50 states. CMS has approved second or third Appendix K submissions from 35 of those states. New approvals are in bold. The number in parentheses indicates the number of approvals.
Alabama | Alaska (2) | Arizona | Arkansas (3) | California (4) | Colorado (5) | Connecticut | Delaware| District of Columbia (2) | Florida | Georgia (3) | Hawaii (4) | Illinois (2) | Indiana | Iowa | Kansas (4) | Kentucky (2) | Louisiana (2) | Maine (2) | Maryland (3) | Massachusetts (2) | Michigan | Minnesota (8) | Mississippi (4) | Missouri (2) | Montana (2) | Nebraska | Nevada (2) | New Hampshire | New Jersey | New Mexico (3) | New York (6) | North Carolina (3) | North Dakota (2) | Ohio (2) | Oklahoma (4) | Oregon (4) | Pennsylvania (6) | Rhode Island | South Carolina | South Dakota (5) | Tennessee | Texas (3) | Utah (2) | Vermont | Virginia (3) | Washington (5) | West Virginia (3) | Wisconsin (2) | Wyoming (6)

Six standalone COVID-19 1115 waivers have been approved. At least 20 COVID-19 1115 waiver requests have been submitted. Italics indicate the waiver has been approved, at least in part. New approvals are in bold.
Arizona | Arkansas | California | Colorado | Georgia | Hawaii | Illinois | Iowa | Massachusetts | Missouri | New Hampshire | New Mexico | New York | North Carolina | Oregon | Rhode Island | South Carolina | Tennessee | Texas | Washington

From September 2 through September 9, CMS approved seven SPAs, four of which are time-limited COVID-19 relief SPAs. The jurisdictions with COVID-19 relief SPAs are Arizona, Idaho, Montana, and North Carolina. Notably, North Carolina’s SPA contains a methodology to provide a supplemental payment to in-state hospitals.

You can find information about all approved Medicaid 1135 waivers here on the Medicaid.gov website.

Sellers Dorsey regularly tracks information about Medicaid at the state and federal levels. If you would like additional information about COVID-19 or topics related to Medicaid, or wish to speak to our experts about other issues facing your organization, please contact us using the form below. We will include you on periodic email updates while we continue to monitor and filter new information.